Table 8. Events at the end of the follow-up.
| Before PS matching |
After PS matching |
|||||
|---|---|---|---|---|---|---|
| Clopidogrel | Prasugrel/Ticagrelor | p | Clopidogrel | Prasugrel/Ticagrelor | p | |
| (n = 448) | (n = 282) | (n = 268) | (n = 268) | |||
| MACE, n (%) | 35 (7.8) | 11 (3.9) | 0.034 | 19 (7.1) | 11 (4.1) | 0.43 |
| Cardiac death | 12 (2.8) | 1 (0.4) | 0.028 | 7 (2.6) | 1 (0.4) | 0.11 |
| Myocardial infarction | 19 (4.4) | 9 (3.6) | 0.590 | 12 (4.5) | 9 (3.4) | 0.99 |
| Stent thrombosis definite | 8 (1.8) | 2 (0.8) | 0.288 | 5 (1.9) | 2 (0.7) | 0.44 |
| Stent thrombosis probable | 4 (0.9) | 1 (0.4) | 0.454 | 1 (0.4) | 1 (0.4) | 0.86 |
| Stroke | 3 (0.7) | 1 (0.4) | 0.621 | 2 (0.7) | 1 (0.4) | 0.41 |
| Bleeding, n (%) | 14 (3.2) | 13 (5.1) | 0.214 | 5 (1.9) | 11 (4.1) | 0.08 |
| Major bleeding | 7 (1.6) | 3 (1.2) | 0.551 | 2 (0.7) | 3 (1.1) | 0.44 |
| Minor bleeding | 7 (1.8) | 10 (4) | 0.091 | 3 (1.1) | 8 (3) | 0.03 |
Values are n (%)